Partners & Collaborators

There are over 160 proteins that misfold and cause disease in the body, including in many rare indications as well as in major diseases (cancer, diabetes). The Treventis team is exploring the use of CCM for designing drugs in these indications and welcomes inquiries for specific collaborations or partnerships in protein misfolding disorders. Please contact us for more information.

Treventis recognizes collaboration and support from the following organizations:

Wellcome
Wellcome
CHUM
CHUM
Servier
Servier
Washington University in St. Louis
Washington University in St. Louis
UHN
UHN
York University
York University
St. Michael
St. Michael
Ontario Centres of Excellence
Ontario Centres of Excellence
University of Toronto
University of Toronto
Atlantic Canada Opportunities Agency
Atlantic Canada Opportunities Agency
BioAdvance
BioAdvance
Columbia University
Columbia University
cqdm
cqdm